Although there is no significant difference in mRNA expression level of FZD9 between PAAD tissues and paracancerous tissues, patients with FZD9 high-expression group had better OS than the low-expression group (p < 0.05). This evidence concerns the gene FZD9 and pancreatic adenocarcinoma.